Ionis Pharmaceuticals, Inc.
(NASDAQ : IONS)

( )
IONS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.50%101.030.0%$1484.62m
BIIBBiogen, Inc. -0.32%243.381.7%$644.21m
AMGNAmgen, Inc. -0.43%222.221.3%$567.12m
GILDGilead Sciences, Inc. -0.37%59.891.0%$536.35m
VRTXVertex Pharmaceuticals, Inc. 1.24%217.871.9%$474.35m
REGNRegeneron Pharmaceuticals, Inc. 0.94%523.612.7%$454.22m
BNTXBioNTech SE 2.34%106.500.0%$445.38m
ILMNIllumina, Inc. 0.35%301.853.5%$377.50m
NVAXNovavax, Inc. 8.59%93.9892.9%$336.34m
EXASEXACT Sciences Corp. 4.61%120.5419.6%$304.90m
MGENMiragen Therapeutics, Inc. 0.35%17.300.7%$272.94m
SRRKScholar Rock Holding Corp. -1.57%41.400.0%$245.77m
APVOAptevo Therapeutics, Inc. -0.18%45.5518.3%$228.01m
SGENSeagen Inc. -3.08%168.075.8%$173.40m
ALXNAlexion Pharmaceuticals, Inc. 1.01%122.612.0%$162.56m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.